Like LH1, we found that high SEPT2 expression level was associated with poor prognosis in HCC (Fig. 7A), PDAC (Fig. 7B), stomach adenocarcinoma (Fig. 7C), and lung adenocarcinoma (Fig. 7D) patients using the KM-Plotter online database. This evidence concerns the gene PLOD1 and hepatocellular carcinoma.